Preimplantation Genetic Testing Market Report by Product (Reagents and Consumables, Instruments), Procedure (Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis), Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Single-Nucleotide Polymorphism), Application (Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormalities, X-Linked Disorders, Human Leukocyte Typing, Gender Identification), and Region 2025-2033

Preimplantation Genetic Testing Market Report by Product (Reagents and Consumables, Instruments), Procedure (Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis), Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Single-Nucleotide Polymorphism), Application (Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormalities, X-Linked Disorders, Human Leukocyte Typing, Gender Identification), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A4192

Market Overview:

The global preimplantation genetic testing market size reached USD 620.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,232.7 Million by 2033, exhibiting a growth rate (CAGR) of 7.54% during 2025-2033.

Report Attribute
 Key Statistics 
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024
USD 620.0 Million
Market Forecast in 2033
USD 1,232.7 Million
Market Growth Rate 2025-2033 7.54%


Preimplantation genetic testing (PGT) identifies abnormal embryos and allows the transfer of genetically normal embryos. It reduces the trauma of multiple failed in vitro fertilization (IVF) cycles and early miscarriages. It also protects children from inherited monogenic disorders. As a result, it is used to treat individuals at high risk of having babies with specific genetic aberrations. It is also utilized in hematological disorders to cure the affected child and in cases of advanced maternal age to avoid the birth of a syndromic child. Nowadays, PGT technology is integrated with Assisted Reproductive Technology (ART) procedures to offer the best outcomes to patients around the world.

Preimplantation Genetic Testing Market Trends:

Chromosomal aneuploidies are one of the leading causes of infertility and maternal age-related reduced fertility. A significant rise in the birth rates and incidences of spontaneous miscarriages represents one of the key factors positively influencing the demand for PGT to reduce the need for multiple IVF cycles. In addition, as the risk of miscarriage grows gradually with the woman’s age, the emerging delayed parenthood trend is catalyzing the demand for PGT across the globe. Apart from this, the rising medical tourism and improving diagnostic modalities are other factors stimulating the market growth. Moreover, the introduction of novel techniques that include microarray and genome sequencing is propelling the market growth. Furthermore, with the discovery of deoxyribonucleic acid (DNA) within the blastocoele fluid (BF) of blastocysts and in spent embryo culture media (SCM), researchers are focusing on developing non-invasive methods of PGT. In confluence with this, the escalating demand for minimally invasive (MI) procedures is contributing to the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global preimplantation genetic testing market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on product, procedure, technology and application.

Breakup by Product:

  • Reagents and Consumables
  • Instruments

Breakup by Procedure:

  • Preimplantation Genetic Screening
  • Preimplantation Genetic Diagnosis

Breakup by Technology:

  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • Fluorescence in Situ Hybridization
  • Comparative Genomic Hybridization
  • Single-Nucleotide Polymorphism

Breakup by Application:

  • Aneuploidy
  • Single Gene Disorder
  • Structural Chromosomal Abnormalities
    • Translocations
    • Deletions
    • Duplications
    • Inversions
  • X-Linked Disorders
  • Human Leukocyte Typing
  • Gender Identification

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., Oxford Gene Technology IP Limited (Sysmex Corporation), PerkinElmer Inc., Quest Diagnostics Incorporated, The Cooper Companies Inc and Thermo Fisher Scientific.

Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Million USD
Segment Coverage Product, Procedure, Technology, Application, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., Oxford Gene Technology IP Limited (Sysmex Corporation), PerkinElmer Inc., Quest Diagnostics Incorporated, The Cooper Companies Inc and Thermo Fisher Scientific
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the global preimplantation genetic testing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global preimplantation genetic testing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the procedure?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global preimplantation genetic testing market and who are the key players?
  • What is the degree of competition in the industry?

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Preimplantation Genetic Testing Market Report by Product (Reagents and Consumables, Instruments), Procedure (Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis), Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Single-Nucleotide Polymorphism), Application (Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormalities, X-Linked Disorders, Human Leukocyte Typing, Gender Identification), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials